India
· Delayed Price · Currency is INR NSE:KREBSBIO Statistics
Total Valuation
NSE:KREBSBIO has a market cap or net worth of INR 1.62 billion. The enterprise value is 3.74 billion.
| Market Cap | 1.62B |
| Enterprise Value | 3.74B |
Important Dates
The last earnings date was Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 21.56M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.74 |
| PB Ratio | -1.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.88 |
| EV / Sales | 8.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -32.64 |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -18.53 |
| Interest Coverage | -3.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -7.56% |
| Return on Invested Capital (ROIC) | -18.70% |
| Return on Capital Employed (ROCE) | -32.07% |
| Revenue Per Employee | 2.27M |
| Profits Per Employee | -1.41M |
| Employee Count | 191 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 0.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.00% in the last 52 weeks. The beta is 0.59, so NSE:KREBSBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +10.00% |
| 50-Day Moving Average | 74.66 |
| 200-Day Moving Average | 86.07 |
| Relative Strength Index (RSI) | 48.76 |
| Average Volume (20 Days) | 8,169 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:KREBSBIO had revenue of INR 433.12 million and -269.39 million in losses. Loss per share was -12.49.
| Revenue | 433.12M |
| Gross Profit | 377.56M |
| Operating Income | -210.10M |
| Pretax Income | -269.24M |
| Net Income | -269.39M |
| EBITDA | -143.21M |
| EBIT | -210.10M |
| Loss Per Share | -12.49 |
Balance Sheet
The company has 1.42 million in cash and 2.12 billion in debt, giving a net cash position of -2.12 billion.
| Cash & Cash Equivalents | 1.42M |
| Total Debt | 2.12B |
| Net Cash | -2.12B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -1.46B |
| Book Value Per Share | -67.74 |
| Working Capital | -932.67M |
Cash Flow
In the last 12 months, operating cash flow was -78.91 million and capital expenditures -35.63 million, giving a free cash flow of -114.54 million.
| Operating Cash Flow | -78.91M |
| Capital Expenditures | -35.63M |
| Free Cash Flow | -114.54M |
| FCF Per Share | n/a |
Margins
Gross margin is 87.17%, with operating and profit margins of -48.51% and -62.20%.
| Gross Margin | 87.17% |
| Operating Margin | -48.51% |
| Pretax Margin | -62.16% |
| Profit Margin | -62.20% |
| EBITDA Margin | -33.06% |
| EBIT Margin | -48.51% |
| FCF Margin | n/a |
Dividends & Yields
NSE:KREBSBIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | n/a |
| Earnings Yield | -16.65% |
| FCF Yield | -7.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |